Connect Biopharma Holdings Ltd

CNTB
As of the close on Sep 25, 2026
Price
$1.08
Market cap
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share
P/E (diluted TTM)
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share
EPS (TTM)
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share
Dividend yield
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Connect Biopharma Holdings Ltd Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Connect Biopharma Holdings Ltd — 10-Q filed Aug 12, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 2, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer Report date Shares Value Filing
EverSource Wealth Advisors, LLC 2026-03-31 1,247 $3.27K SEC filing
EverSource Wealth Advisors, LLC 2025-12-31 1,288 $3.63K SEC filing
EverSource Wealth Advisors, LLC 2025-09-30 1,582 Not shown SEC filing
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 2025-06-30 0 $0 SEC filing
Koa Wealth Management, LLC 2025-06-30 49,600 Not shown SEC filing
ADAR1 Capital Management, LLC 2025-06-30 10,300 Not shown SEC filing
RENAISSANCE TECHNOLOGIES LLC 2025-06-30 143,700 Not shown SEC filing
EverSource Wealth Advisors, LLC 2025-06-30 1,582 Not shown SEC filing
BML Capital Management, LLC 2025-06-30 1,821,558 Not shown SEC filing
COMMONWEALTH EQUITY SERVICES, LLC 2025-06-30 20,000 Not shown SEC filing
UBS Group AG 2025-06-30 42 Not shown SEC filing
SBI Securities Co., Ltd. 2025-06-30 6 Not shown SEC filing
Royal Bank of Canada 2025-06-30 40,400 Not shown SEC filing
RHUMBLINE ADVISERS 2025-06-30 2,370 Not shown SEC filing
Royal Bank of Canada 2025-06-30 40,400 Not shown SEC filing
MORGAN STANLEY 2025-06-30 100 Not shown SEC filing
CHOREO, LLC 2025-06-30 160,867 Not shown SEC filing
CITADEL ADVISORS LLC 2025-06-30 61,992 Not shown SEC filing
GEODE CAPITAL MANAGEMENT, LLC 2025-06-30 23,320 Not shown SEC filing
AlphaCore Capital LLC 2025-06-30 80,000 Not shown SEC filing
  • Each value is checked against Connect Biopharma Holdings Ltd's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
  • Value not shown for 17 rows: no share price from within three months of their report dates is on file, so they could not be checked.

Filer report history

Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.

  • EverSource Wealth Advisors, LLC: 1,288 shares reported 2025-12-31; 1,247 shares reported 2026-03-31.
  • EverSource Wealth Advisors, LLC: 1,582 shares reported 2025-09-30; 1,288 shares reported 2025-12-31.
  • EverSource Wealth Advisors, LLC: 1,582 shares reported 2025-06-30; 1,582 shares reported 2025-09-30.
  • JPMORGAN CHASE & CO: 121 shares reported 2025-03-31; 121 shares reported 2025-06-30.
  • GEODE CAPITAL MANAGEMENT, LLC: 27,961 shares reported 2025-03-31; 23,320 shares reported 2025-06-30.
  • CHOREO, LLC: 160,867 shares reported 2025-03-31; 160,867 shares reported 2025-06-30.
  • RHUMBLINE ADVISERS: 2,370 shares reported 2025-03-31; 2,370 shares reported 2025-06-30.
  • SBI Securities Co., Ltd.: 6 shares reported 2025-03-31; 6 shares reported 2025-06-30.
  • UBS Group AG: 8,739 shares reported 2025-03-31; 42 shares reported 2025-06-30.
  • COMMONWEALTH EQUITY SERVICES, LLC: 20,000 shares reported 2025-03-31; 20,000 shares reported 2025-06-30.
  • BML Capital Management, LLC: 2,093,232 shares reported 2025-03-31; 1,821,558 shares reported 2025-06-30.
  • RENAISSANCE TECHNOLOGIES LLC: 114,800 shares reported 2025-03-31; 143,700 shares reported 2025-06-30.

Showing the 12 most recent filer reports.

10 filers have only one report here.

Purchases & sales (open market or private)

SecurityCodePriceFiling
2026-05-29Huang James · DirectorOrdinary SharesP — Open market or private purchase+150,0002.48SEC filing
2026-03-31Huang James · DirectorOrdinary SharesP — Open market or private purchase+1,160,0003.45SEC filing

Showing 2 of 2 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-03-31Xanthopoulos Kleanthis Gabriel · DirectorOrdinary SharesA — Grant, award, or other acquisition+2,816SEC filing
2026-03-31LIU JEAN I · DirectorOrdinary SharesA — Grant, award, or other acquisition+5,061SEC filing

Showing 2 of 2 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.